WallStSmart
HBIO

Harvard Bioscience Inc

NASDAQ: HBIO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$6.38
+4.08% today

Updated 2026-04-30

Market cap
$30.80M
P/E ratio
P/S ratio
0.36x
EPS (TTM)
$-12.80
Dividend yield
52W range
$3 – $9
Volume
0.2M

Harvard Bioscience Inc (HBIO) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$8.36M$12.05M$9.20M$16.51M$12.29M$6.35M$8.06M$4.06M$4.35M$705000.00$5.38M$1.06M$2.34M$8.05M$9.33M$1.26M$1.15M$14.03M$1.44M$6.73M
Capital expenditures$2.39M$1.45M$1.31M$1.38M$844000.00$1.51M$1.83M$1.68M$2.00M$2.98M$1.48M$890000.00$986000.00$1.22M$1.15M$1.34M$1.59M$2.31M$3.26M$1.11M
Depreciation
Stock-based comp$2.11M$2.40M$2.01M$2.51M$2.76M$2.86M$3.32M$2.67M$2.16M$2.75M$3.50M$3.50M$3.04M$3.03M$3.65M$4.17M$4.41M$5.00M$4.34M$-1.67M
Free cash flow$5.97M$10.60M$7.89M$15.13M$11.45M$4.84M$6.23M$2.38M$2.35M$-2.27M$3.90M$167000.00$1.36M$6.83M$8.18M$-83000.00$-438000.00$11.72M$-1.82M$5.62M
Investing cash flow
Financing cash flow
Dividends paid$19.03M$10.07M$4.43M$0.00$0.00$0.00$0.00$0.00$0.00$221000.00$200000.00$1.63M
Share repurchases
Debt repayment
Net change in cash$-1.79M$2.77M$5.09M$-11.64M$-7.39M$-1.15M$137000.00$2.44M$192000.00$-38000.00$-335000.00$-3.27M